Auf dieser Seite
CTSO Cytosorbents Corporation - Common Stock
NASDAQ · Health Care · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 6, 2026
$4,05
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$3,7752-Wochen-Tief
$20,4052-Wochen-Hoch
Marktkapitalisierung (MRQ)
$255M
P/E (TTM)
-14.0
EPS (TTM)
$-0.29
Umsatz (TTM)
$37M
Ihre Abzeichen
52W-Spanne
$4–$20
Analystenbewertung
HOLD
Kursziel
$48
P/E
-14.0
ROE
-336.2%
Nettogewinnmarge
-48.9%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
CTSO Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$4.05
Marktkapitalisierung (MRQ)
$255M
P/E (TTM)
-14.0
EPS (TTM)
$-0.29
Umsatz (TTM)
$37M
ROE (TTM)
-336.2%
Verschuldungsgrad (MRQ)
-23.0
52W-Spanne
$4–$20
CTSO Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 8. September 2026 | 1-for-20 | Umgekehrt |
| 5. Dezember 2014 | 1-for-25 | Umgekehrt |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$37M2022-12-31 → 2025-12-31
EPS$-0.132022-12-31 → 2025-12-31
Freier Cashflow·2022-12-31 → 2024-12-31
Nettogewinnmarge-48.9%2022-12-31 → 2024-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | CTSO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -14.0 | · | · | · | |
| P/S (TTM) | 6.8 | · | 2.8 | Unterbewertet | |
| K/B (MRQ) | -338.9 | · | · | · | |
| Kurs / FCF (TTM) | -27.4 | · | · | · | |
| Kurs / Cashflow (TTM) | -27.8 | · | · | · | |
| Kurs / Materieller Buchwert (MRQ) | -70.4 | · | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | CTSO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Bruttogewinnmarge (TTM) | 71.6% | · | 60.7% | Spitzenklasse | |
| Betriebsgewinnmarge (TTM) | -34.7% | · | -121.2% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | -48.9% | · | -93.2% | Spitzenklasse | |
| ROA (TTM) | -42.4% | · | -44.6% | Spitzenklasse | |
| ROE (TTM) | -336.2% | · | -93.8% | Im Einklang |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | CTSO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | -23.0 | · | 0.0 | Geringe Verschuldung | |
| Liquiditätsgrad (MRQ) | 0.7 | · | 2.1 | Geringe Liquidität | |
| Langfristige Schulden / Eigenkapital (MRQ) | -4.1 | · | · | · |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | CTSO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 4.1% | · | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 2.2% | · | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | -2.0% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | CTSO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$287.3K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-8.9%
Nächster Bericht
Nov 03, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 10, 2026 | $-1.40 | $-0.92 | -52.5% |
| 31. März 2026 | Mai 13, 2026 | $-1.60 | $-1.12 | -42.6% |
| 31. Dezember 2025 | $-0.09 | $-0.05 | -76.5% | |
| 30. September 2025 | $-0.05 | $-0.05 | -5.0% | |
| 30. Juni 2025 | $0.03 | $-0.05 | 158.8% | |
| 31. März 2025 | $-0.02 | $-0.07 | 72.0% | |
| 31. Dezember 2024 | $-0.14 | $-0.06 | -116.7% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $37M | $36M | $31M | $35M | $43M | $41M | $25M | $23M | $15M | $10M | $5M | $4M | |
| Cost of Revenue | $11M | $11M | $9M | $14M | $11M | $11M | $7M | $7M | $6M | $4M | $2M | $2M | |
| Gross Profit | $26M | $25M | $22M | $21M | $32M | $30M | $18M | $15M | $10M | $6M | $3M | $2M | |
| R&D Expense | · | · | $16M | $15M | $16M | $9M | $12M | $8M | $3M | $4M | $4M | $2M | |
| SG&A Expense | $36M | $34M | $38M | $34M | $36M | $28M | $22M | $21M | $15M | $12M | $7M | $6M | |
| Operating Expenses | $41M | $41M | $54M | $52M | $55M | $40M | $37M | $31M | $19M | $17M | $12M | $9M | |
| Operating Income | $-15M | $-16M | $-32M | $-32M | $-23M | $-10M | $-19M | $-16M | $-10M | $-11M | $-9M | $-7M | |
| Other Non-op | $6M | $-6M | $2M | $-2M | $-3M | $1M | $-1M | $-2M | $705.1K | $-589.9K | $-498.0K | $-3M | |
| Pretax Income | $-9M | $-22M | $-30M | $-34M | $-25M | $-9M | $-20M | $-18M | $-9M | $-12M | $-10M | $-10M | |
| Income Tax | $-401.0K | $-2M | $-813.7K | $-1M | $-736.0K | $-1M | $-1M | $-619.5K | $-676.7K | $-318.6K | $-324.6K | $-385.6K | |
| Net Income | $-8M | $-21M | $-29M | $-33M | $-25M | $-8M | $-19M | $-17M | $-8M | $-12M | $-9M | $-9M | |
| EPS (Basic) | $-0.13 | $-0.38 | $-0.65 | $-0.75 | $-0.57 | $-0.20 | $-0.60 | · | · | · | · | · | |
| EPS (Diluted) | $-0.13 | $-0.38 | $-0.65 | $-0.75 | $-0.57 | $-0.20 | $-0.60 | · | · | · | · | · | |
| Shares (Basic) | 62,231,771 | 54,434,609 | 44,656,391 | 43,573,215 | 43,359,186 | 38,818,990 | 32,255,253 | · | · | · | · | · | |
| Shares (Diluted) | 62,231,771 | 54,434,609 | 44,656,391 | 43,573,215 | 43,359,186 | 38,818,990 | 32,255,253 | · | · | · | · | · | |
| EBITDA | · | $-17M | $-31M | $-32M | $-23M | $-10M | $-19M | $-16M | $-10M | $-11M | $-9M | $-7M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6M | $3M | $14M | $22M | $52M | $71M | $12M | $22M | $17M | $5M | $5M | $4M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | $0 | $2M | $2M | |
| Receivables | $8M | $7M | $6M | $6M | $5M | $5M | $4M | $4M | $2M | $1M | $648.9K | $819.2K | |
| Inventory | $5M | $3M | $3M | $3M | $5M | $3M | $2M | $833.1K | $795.7K | $834.0K | $1M | $537.6K | |
| Prepaid Expense | $2M | $3M | $2M | $2M | $3M | $3M | $2M | $1M | $416.0K | $315.8K | $511.9K | $700.5K | |
| Current Assets | $21M | $22M | $25M | $34M | $64M | $82M | $21M | $28M | $21M | $8M | $10M | $8M | |
| PP&E (Net) | $8M | $9M | $10M | $11M | $5M | $2M | $2M | $2M | $1M | $569.4K | $557.3K | $245.8K | |
| PP&E (Gross) | $13M | $13M | $13M | $13M | $10M | $6M | $6M | $5M | $4M | $3M | $3M | $3M | |
| Accum. Depreciation | $5M | $4M | $3M | $2M | $5M | $4M | $4M | $3M | $3M | $3M | $3M | $2M | |
| Intangibles | $3M | $4M | $4M | $4M | $5M | $4M | $3M | $3M | $2M | · | · | · | |
| Other Non-current Assets | $53.0K | $50.0K | $4M | $4M | $5M | $4M | $3M | $3M | $2M | $1M | $836.7K | $615.8K | |
| Total Assets | $44M | $47M | $53M | $63M | $90M | $90M | $27M | $34M | $24M | $10M | $11M | $8M | |
| Accounts Payable | $3M | $3M | $4M | $2M | $3M | $2M | $2M | $1M | $1M | $1M | $684.6K | $698.3K | |
| Accrued Liabilities | · | · | $497.6K | $850.6K | $1M | $631.6K | $629.2K | $479.8K | $310.2K | $44.9K | · | · | |
| Current Liabilities | $10M | $10M | $14M | $10M | $14M | $10M | $10M | $7M | $8M | $4M | $3M | $5M | |
| Capital Leases | $12M | $12M | $13M | $13M | $13M | $581.6K | $642.7K | $1M | · | · | · | · | |
| Total Liabilities | $38M | $36M | $29M | $28M | $27M | $11M | $24M | $17M | $14M | $8M | $3M | · | |
| Long-term Debt | $17M | · | $5M | · | · | $0 | $15M | $10M | $10M | $5M | $0 | · | |
| Total Debt | · | $14M | $5M | $5M | · | $0 | $15M | $10M | $10M | $5M | · | · | |
| Common Stock | $63.0K | $55.0K | $54.2K | $43.6K | $43.5K | $43.2K | $32.6K | $31.8K | $29.0K | $25.5K | $25.4K | $23.3K | |
| Paid-in Capital | $321M | $311M | $306M | $287M | $283M | $278M | $192M | $186M | $163M | $144M | $140M | $128M | |
| Retained Earnings | $-312M | $-304M | $-283M | $-254M | $-221M | $-197M | $-189M | $-170M | $-152M | $-144M | $-133M | $-124M | |
| AOCI | $-3M | $4M | $529.3K | $2M | $525.6K | $-2M | $526.0K | $288.2K | $-361.0K | $898.7K | $584.3K | $227.7K | |
| Stockholders' Equity | $6M | $11M | $23M | $35M | $63M | $79M | $3M | $17M | $10M | $1M | $10M | $7M | |
| Liabilities + Equity | $44M | $47M | $53M | $63M | $90M | $90M | $27M | $34M | $24M | $10M | $11M | $8M | |
| Shares Outstanding | 62,804,305 | 54,830,146 | 54,240,265 | 43,635,715 | 43,635,715 | 43,221,999 | 32,616,107 | 31,774,139 | 28,973,679 | 25,483,966 | 25,397,056 | 23,304,640 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $1M | $1M | $882.6K | $731.6K | $660.8K | $581.5K | $390.6K | $218.3K | $161.6K | $113.0K | $65.5K | |
| Stock-based Comp | $3M | $4M | $4M | $3M | $4M | $4M | $2M | $4M | $3M | $3M | $382.3K | $695.8K | |
| Amort. of Intangibles | $262.0K | $235.0K | · | · | · | · | · | · | · | · | · | · | |
| Restructuring | $510.0K | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-12M | $-14M | $-22M | $-28M | $-14M | $-6M | $-17M | $-11M | $-6M | $-7M | $-9M | $-6M | |
| CapEx | $164.0K | $284.0K | $538.1K | $6M | $4M | $708.4K | $698.2K | $672.0K | $990.7K | $140.7K | $403.6K | $153.2K | |
| Investing Cash Flow | $-415.0K | $-669.0K | $-936.2K | $-6M | $-4M | $-2M | $-2M | $-2M | $-2M | $2M | $-890.9K | $-2M | |
| Debt Issued | $2M | $15M | · | $5M | · | $1M | $5M | $666.7K | $5M | $5M | $0 | $0 | |
| Net Debt Issued | · | $10M | · | $5M | · | $-15M | $5M | $0 | $5M | $5M | · | · | |
| Stock Issued | · | · | · | · | $27M | $27M | $14M | $10M | $10M | · | · | · | |
| Net Stock Activity | · | · | · | · | $27M | $27M | $14M | $10M | $10M | · | · | · | |
| Financing Cash Flow | $9M | $9M | $14M | $5M | $715.2K | $66M | $8M | $17M | $20M | $5M | $12M | $10M | |
| Net Change in Cash | $-2M | $-6M | $-8M | $-30M | $-18M | $59M | $-10M | $5M | $12M | $-71.7K | $2M | $1M | |
| Taxes Paid | $-2M | $-881.0K | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $-15M | $-22M | $-34M | $-18M | $-6M | $-17M | $-12M | $-7M | $-7M | $-9M | $-7M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 70.6% | 61.6% | 59.8% | 74.4% | 73.0% | 70.5% | 66.7% | 63.6% | 58.5% | 53.8% | 48.2% | |
| Operating Margin | · | -47.2% | -85.9% | -90.9% | -52.7% | -25.3% | -76.0% | -69.2% | -65.0% | -120.6% | -194.2% | -176.6% | |
| Net Margin | · | -58.2% | -78.4% | -94.6% | -56.9% | -19.1% | -77.2% | -76.5% | -55.8% | -125.3% | -169.7% | -226.1% | |
| Pretax Margin | · | -63.0% | -80.7% | -97.7% | -58.6% | -21.9% | -81.6% | -79.2% | -60.3% | -128.7% | -176.5% | -235.4% | |
| EBITDA Margin | · | -47.2% | -85.9% | -90.9% | -52.7% | -25.3% | -76.0% | -69.2% | -65.0% | -120.6% | -194.2% | -176.6% | |
| ROA | · | -43.5% | -56.5% | -43.0% | -27.4% | -13.4% | -62.6% | -60.6% | -50.1% | -114.0% | -82.5% | -149.0% | |
| ROE | · | -169.2% | -135.5% | -88.1% | -36.9% | -9.8% | -379.6% | -93.0% | -145.9% | -254.8% | -107.3% | 181.0% | |
| ROIC | · | -61.8% | -107.1% | -75.6% | -35.3% | -11.5% | -97.2% | -56.0% | -45.0% | -252.2% | -109.0% | -176.4% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 2.2 | 1.8 | 3.5 | 4.7 | 8.1 | 2.1 | 4.3 | 2.6 | 1.3 | 3.2 | 1.7 | |
| Quick Ratio | · | 1.1 | 1.4 | 2.9 | 4.1 | 7.5 | 1.7 | 4.0 | 2.5 | 1.1 | 2.7 | 1.2 | |
| Debt / Equity | · | 1.3 | 0.2 | 0.1 | · | 0.0 | 4.4 | 0.6 | 1.0 | -10.4 | · | · | |
| LT Debt / Equity | · | 1.3 | 0.1 | 0.1 | · | 0.0 | 3.9 | 0.5 | 0.6 | -8.6 | · | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.7 | 0.7 | 0.5 | 0.5 | 0.7 | 0.8 | 0.8 | 0.9 | 0.9 | 0.5 | 0.7 | |
| Inventory Turnover | · | 3.5 | 4.2 | 3.4 | 3.0 | 4.6 | 5.0 | 9.2 | 6.8 | 3.9 | 2.6 | 5.4 | |
| Receivables Turnover | · | 5.3 | 6.2 | 6.8 | 8.9 | 8.5 | 5.9 | 7.3 | 8.3 | 9.2 | 6.5 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $0.20 | $0.43 | $0.81 | $1.44 | $1.83 | $0.10 | $0.53 | $0.35 | $-0.02 | $0.32 | $0.17 | |
| Revenue / Share | · | $0.65 | $0.81 | $0.80 | $1.00 | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | $-0.27 | $-0.48 | $-0.65 | $-0.32 | · | · | · | · | · | · | · | |
| Cash / Share | · | $0.06 | $0.26 | $0.51 | $1.20 | $1.65 | $0.38 | $0.70 | $0.60 | $0.21 | $0.21 | $0.15 | |
| EPS (TTM) | $-0.13 | $-0.38 | $-0.65 | $-0.75 | $-0.57 | $-0.20 | $-0.60 | $-0.26 | $-0.26 | $-0.26 | $-0.33 | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 4.1% | 14.5% | -10.4% | -19.6% | 5.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 2.2% | -6.2% | -8.8% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -2.0% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $37M | $36M | $31M | $35M | $43M | $41M | $25M | $23M | $15M | $10M | $5M | $4M | |
| Net Income TTM | $-8M | $-21M | $-29M | $-33M | $-25M | $-8M | $-19M | $-17M | $-8M | $-12M | $-9M | $-9M | |
| Market Cap | · | $50M | $60M | $67M | $182M | $344M | $126M | $257M | $188M | $139M | $141M | $232M | |
| Enterprise Value | · | $61M | $51M | $50M | · | $273M | $128M | $244M | $181M | $139M | · | · | |
| P/E | -4.9 | -2.4 | -1.7 | -2.1 | -7.4 | -39.9 | -6.4 | -31.1 | -25.0 | -21.0 | -16.9 | · | |
| P/S | · | 1.4 | 1.9 | 1.9 | 4.2 | 8.4 | 5.0 | 11.4 | 12.4 | 14.6 | 29.5 | 56.2 | |
| P/B | · | 4.5 | 2.6 | 1.9 | 2.9 | 4.3 | 36.7 | 15.2 | 18.4 | -293.0 | 17.2 | 58.5 | |
| P / Tangible Book | 15.0 | 6.8 | 3.1 | 2.2 | 3.1 | 4.6 | · | · | · | · | · | · | |
| P / Cash Flow | · | -3.5 | -2.8 | -2.4 | -13.0 | -61.4 | -7.5 | -23.7 | -29.1 | -20.6 | -15.7 | -34.8 | |
| P / FCF | · | -3.4 | -2.7 | -2.0 | -10.3 | -54.5 | -7.2 | -22.3 | -25.3 | -20.2 | -15.0 | -34.0 | |
| EV / EBITDA | · | -3.6 | -1.6 | -1.6 | · | -26.3 | -6.8 | -15.7 | -18.4 | -12.1 | · | · | |
| EV / FCF | · | -4.1 | -2.3 | -1.5 | · | -43.2 | -7.4 | -21.2 | -24.3 | -20.2 | · | · | |
| EV / Revenue | · | 1.7 | 1.6 | 1.4 | · | 6.7 | 5.1 | 10.9 | 11.9 | 14.5 | · | · | |
| Earnings Yield | -20.3% | -41.8% | -58.6% | -48.4% | -13.6% | -2.5% | -15.6% | -3.2% | -4.0% | -4.8% | -5.9% | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10M | $9M | $9M | $9M | $10M | $9M | $9M | $9M | $9M | $9M | $3M | $9M | $9M | $9M | $9M | $8M | |
| Cost of Revenue | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $-1M | $3M | $3M | $4M | $4M | $4M | |
| Gross Profit | $7M | $6M | $7M | $7M | $7M | $6M | $6M | $5M | $7M | $7M | $5M | $6M | $6M | $5M | $6M | $4M | |
| R&D Expense | $1M | $1M | · | · | $1M | $2M | · | $2M | $2M | $2M | · | $4M | $4M | $4M | $3M | $3M | |
| SG&A Expense | $8M | $8M | $9M | $9M | $9M | $8M | $8M | $8M | $9M | $9M | $14M | $8M | $8M | $8M | $8M | $9M | |
| Operating Expenses | $10M | $9M | $11M | $10M | $10M | $10M | $10M | $10M | $10M | $12M | $15M | $13M | $13M | $13M | $12M | $13M | |
| Operating Income | $-3M | $-3M | $-4M | $-3M | $-4M | $-4M | $-3M | $-5M | $-4M | $-5M | $-10M | $-7M | $-7M | $-8M | $-6M | $-9M | |
| Other Non-op | $-2M | $-2M | $-1M | $-709.0K | $6M | $2M | $-6M | $2M | $-724.0K | $-1M | $3M | $-2M | $406.2K | $565.7K | $4M | $-3M | |
| Pretax Income | · | · | $-5M | $-4M | · | $-1M | $-9M | $-3M | $-4M | $-6M | $-7M | $-9M | $-6M | $-7M | $-2M | $-12M | |
| Income Tax | $0 | $0 | $0 | $-401.0K | $0 | $0 | $-2M | $0 | $0 | $0 | $-813.7K | $0 | · | · | $-1M | $0 | |
| Net Income | $-4M | $-5M | $-5M | $-3M | $2M | $-1M | $-8M | $-3M | $-4M | $-6M | $-7M | $-9M | $-6M | $-7M | $-766.1K | $-12M | |
| EPS (Basic) | $-0.07 | $-0.08 | $-0.09 | $-0.05 | $0.03 | $-0.02 | $-0.14 | $-0.05 | $-0.08 | $-0.11 | $-0.13 | $-0.21 | $-0.15 | $-0.17 | $-0.02 | $-0.28 | |
| EPS (Diluted) | $-0.07 | $-0.08 | $-0.09 | $-0.05 | $0.03 | $-0.02 | $-0.14 | $-0.05 | $-0.08 | $-0.11 | $-0.13 | $-0.21 | $-0.15 | $-0.17 | $-0.02 | $-0.28 | |
| Shares (Basic) | 62,806,694 | 62,738,827 | · | 62,753,959 | 62,608,598 | 60,731,929 | · | 54,453,006 | 54,306,041 | 54,434,609 | · | 44,373,969 | 44,015,380 | 43,676,435 | · | 43,606,980 | |
| Shares (Diluted) | 62,806,694 | 62,738,827 | · | 62,753,959 | 67,166,377 | 60,731,929 | · | 54,453,006 | 54,306,041 | 54,434,609 | · | 44,373,969 | 44,015,380 | 43,676,435 | · | 43,606,980 | |
| EBITDA | $-3M | $-3M | · | $-3M | $-4M | $-4M | · | $-4M | $-3M | $-5M | · | $-7M | $-7M | $-8M | · | $-9M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $5M | $6M | $8M | $10M | $12M | $3M | $6M | $8M | $9M | $14M | $8M | $13M | $19M | $22M | $23M | |
| Receivables | $7M | $7M | $8M | $7M | $8M | $8M | $7M | $7M | $8M | $7M | $6M | $6M | $7M | $6M | $6M | $5M | |
| Inventory | $4M | $4M | $5M | $4M | $4M | $3M | $3M | $3M | $4M | $4M | $3M | $3M | $2M | $2M | $3M | $4M | |
| Prepaid Expense | $852.0K | $1M | $2M | $2M | $1M | $3M | $3M | $1M | $1M | $880.4K | $2M | $2M | $1M | $2M | $2M | $1M | |
| Current Assets | $16M | $18M | $21M | $21M | $23M | $25M | $22M | $17M | $22M | $20M | $25M | $19M | $24M | $28M | $34M | $32M | |
| PP&E (Net) | $7M | $8M | $8M | $8M | $8M | $9M | $9M | $9M | $9M | $10M | $10M | $10M | $11M | $11M | $11M | $11M | |
| PP&E (Gross) | $13M | $13M | $13M | $13M | $13M | $13M | $13M | · | · | · | $13M | · | · | · | $13M | · | |
| Accum. Depreciation | $6M | $5M | $5M | $5M | $5M | $5M | $4M | · | · | · | $3M | · | · | · | $2M | · | |
| Intangibles | $3M | $3M | $3M | $4M | $4M | $4M | $4M | · | · | · | $4M | · | · | · | $4M | · | |
| Other Non-current Assets | $53.0K | $52.0K | $53.0K | $4M | $4M | $4M | $50.0K | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | |
| Total Assets | $38M | $41M | $44M | $46M | $48M | $51M | $47M | $48M | $53M | $47M | $53M | $48M | $52M | $57M | $63M | $62M | |
| Accounts Payable | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $2M | $4M | $3M | $3M | $3M | $2M | $2M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $850.6K | · | |
| Current Liabilities | $24M | $16M | $10M | $10M | $10M | $10M | $10M | $8M | $10M | $13M | $14M | $12M | $10M | $10M | $10M | $10M | |
| Capital Leases | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $13M | $13M | $13M | $13M | $13M | $13M | $13M | $13M | $13M | |
| Total Liabilities | $39M | $38M | $38M | $37M | $36M | $36M | $36M | $35M | $37M | $28M | $29M | $29M | $28M | $29M | $28M | $23M | |
| Long-term Debt | $17M | $17M | · | · | · | · | · | $14M | $14M | $4M | $5M | $5M | $5M | $5M | · | · | |
| Total Debt | $17M | $17M | · | $15M | $14M | $14M | · | $14M | $14M | $4M | · | $5M | $5M | · | · | · | |
| Common Stock | $63.0K | $63.0K | $63.0K | $63.0K | $63.0K | $62.5K | $55.0K | $54.5K | $54.3K | $54.3K | $54.2K | $44.4K | $44.2K | $43.9K | $43.6K | $43.6K | |
| Paid-in Capital | $322M | $322M | $321M | $320M | $319M | $318M | $311M | $308M | $308M | $306M | $306M | $292M | $290M | $289M | $287M | $286M | |
| Retained Earnings | $-322M | $-317M | $-312M | $-307M | $-304M | $-305M | $-304M | $-295M | $-293M | $-289M | $-283M | $-277M | $-267M | $-261M | $-254M | $-253M | |
| AOCI | $-996.0K | $-2M | $-3M | $-4M | $-4M | $2M | $4M | $-156.9K | $2M | $2M | $529.3K | $3M | $1M | $2M | $2M | $6M | |
| Stockholders' Equity | $-751.0K | $2M | $6M | $9M | $12M | $15M | $11M | $13M | $17M | $19M | $23M | $19M | $24M | $29M | $35M | $39M | |
| Liabilities + Equity | $38M | $41M | $44M | $46M | $48M | $51M | $47M | $48M | $53M | $47M | $53M | $48M | $52M | $57M | $63M | $62M | |
| Shares Outstanding | 62,842,748 | 62,733,305 | 62,804,305 | 62,794,305 | 62,610,376 | 62,529,466 | 54,830,146 | 54,500,613 | 54,306,415 | 54,293,555 | 54,240,265 | 43,851,380 | 43,851,380 | 43,851,380 | 43,635,715 | 43,634,845 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $97.0K | $364.0K | $404.5K | $368.5K | $154.0K | $383.1K | $400.7K | $397.3K | $391.3K | $407.2K | $402.0K | $258.6K | $223.2K | $213.1K | |
| Stock-based Comp | $368.0K | $544.0K | $887.6K | $488.0K | $571.0K | $818.0K | $920.5K | $891.0K | $989.0K | $959.5K | $2M | $1M | $570.2K | $830.3K | $869.4K | $1M | |
| Amort. of Intangibles | $60.0K | $61.0K | · | · | $60.0K | $63.0K | · | · | · | · | · | · | · | · | · | · | |
| Restructuring | $270.0K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-583.0K | $-1M | $-5M | $-3M | $-2M | $-3M | $-2M | $-2M | $-5M | $-5M | $-6M | $-5M | $-7M | $-3M | $-5M | $-7M | |
| CapEx | $14.0K | $11.0K | $108.0K | $17.0K | $36.9K | $2.0K | $69.0K | $152.0K | $17.8K | $45.2K | $95.5K | $142.4K | $-209.4K | $509.7K | $213.4K | $639.8K | |
| Investing Cash Flow | $7.0K | $-46.0K | $-291.0K | $55.0K | $-131.8K | $-47.0K | $-124.0K | $-298.1K | $-119.0K | $-127.0K | $-135.9K | $-257.7K | $140.3K | $-682.9K | $-206.1K | $-716.5K | |
| Debt Issued | · | · | · | · | · | · | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $-625.0K | · | · | · | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | · | · | $53.2K | · | · | · | $641.7K | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $53.2K | · | · | · | · | · | · | |
| Financing Cash Flow | · | · | $2M | $0 | $-1.1K | $7M | $167.0K | $-98.9K | $10M | $-571.8K | $12M | $648.3K | $931.1K | $684.3K | $5M | $0 | |
| Net Change in Cash | $-400.0K | $-1M | $-1M | $-3M | $-1M | $3M | $-2M | $-3M | $5M | $-6M | $6M | $-5M | $-6M | $-3M | $-407.7K | $-8M | |
| Free Cash Flow | · | $-1M | · | · | · | $-3M | · | · | · | $-5M | · | · | · | $-4M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 73.2% | 69.2% | · | 70.3% | 70.9% | 71.1% | · | 56.2% | 65.7% | 67.1% | · | 63.6% | 63.9% | 57.7% | · | 44.6% | |
| Operating Margin | -27.4% | -34.3% | · | -30.2% | -37.6% | -44.5% | · | -46.8% | -34.5% | -50.3% | · | -83.4% | -69.6% | -83.5% | · | -111.2% | |
| Net Margin | -45.9% | -57.9% | · | -33.4% | 20.2% | -16.9% | · | -24.9% | -41.9% | -65.0% | · | -104.3% | -65.3% | -77.5% | · | -150.4% | |
| Pretax Margin | · | · | · | -37.6% | · | -16.9% | · | -24.9% | -41.9% | -65.0% | · | -104.3% | -65.3% | -77.5% | · | -150.4% | |
| EBITDA Margin | -27.4% | -34.3% | · | -30.2% | -37.6% | -44.5% | · | -46.8% | -34.5% | -50.3% | · | -83.4% | -69.6% | -83.5% | · | -111.2% | |
| ROA | -10.3% | -11.2% | · | -6.8% | 3.8% | -3.0% | · | -4.9% | -7.8% | -12.2% | · | -16.7% | -10.0% | -10.4% | · | -15.5% | |
| ROE | -81.5% | -61.3% | · | -28.8% | 13.8% | -8.8% | · | -14.8% | -20.3% | -26.6% | · | -31.9% | -17.2% | -17.4% | · | -22.2% | |
| ROIC | · | · | · | -10.8% | · | -13.5% | · | -16.4% | · | · | · | · | · | · | · | -23.0% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.7 | 1.1 | · | 2.1 | 2.3 | 2.6 | · | 2.0 | 2.1 | 1.5 | · | 1.6 | 2.3 | 2.7 | · | 3.2 | |
| Quick Ratio | 0.5 | 0.7 | · | 1.5 | 1.8 | 2.0 | · | 1.5 | 1.6 | 1.1 | · | 1.2 | 1.9 | 2.4 | · | 2.7 | |
| Debt / Equity | -23.0 | 7.7 | · | 1.6 | 1.2 | 1.0 | · | 1.1 | 0.8 | 0.2 | · | 0.3 | 0.2 | · | · | · | |
| LT Debt / Equity | -4.1 | 4.7 | · | 1.6 | 1.2 | 1.0 | · | 1.1 | 0.8 | 0.1 | · | 0.2 | 0.2 | · | · | · |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.7 | 0.7 | · | 0.8 | 0.7 | 0.7 | · | 1.3 | 1.1 | 1.2 | · | 1.0 | 1.0 | 1.1 | · | 1.1 | |
| Receivables Turnover | 1.3 | 1.2 | · | 1.3 | 1.2 | 1.2 | · | 1.5 | 1.3 | 1.6 | · | 1.6 | 1.5 | 1.9 | · | 1.6 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.01 | $0.04 | · | $0.14 | $0.18 | $0.23 | · | $0.24 | $0.31 | $0.35 | · | $0.42 | $0.55 | $0.66 | · | $0.90 | |
| Revenue / Share | $0.15 | $0.14 | · | $0.15 | $0.14 | $0.14 | · | $0.17 | $0.18 | $0.18 | · | $0.20 | $0.21 | · | · | $0.19 | |
| Cash Flow / Share | · | $-0.02 | · | · | · | $-0.06 | · | · | · | $-0.09 | · | · | · | · | · | · | |
| Cash / Share | $0.07 | $0.08 | · | $0.12 | $0.16 | $0.19 | · | $0.10 | $0.16 | $0.16 | · | $0.19 | $0.30 | $0.43 | · | $0.52 | |
| EPS (TTM) | $-0.29 | $-0.19 | · | $-0.18 | $-0.18 | $-0.29 | · | $-0.37 | $-0.53 | $-0.60 | · | $-0.55 | $-0.62 | $-0.72 | · | $-0.99 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $37M | $37M | · | $37M | $36M | $35M | · | $30M | $30M | $31M | · | $37M | $36M | $35M | · | $36M | |
| Net Income TTM | $-18M | $-12M | · | $-10M | $-10M | $-16M | · | $-20M | $-26M | $-28M | · | $-23M | $-26M | $-31M | · | $-41M | |
| Market Cap | $24M | $36M | · | $59M | $80M | $63M | · | $82M | $38M | $52M | · | $82M | $157M | $148M | · | $59M | |
| Enterprise Value | $36M | $48M | · | $66M | $84M | $65M | · | $90M | $43M | $47M | · | $79M | $149M | · | · | · | |
| P/E | -1.3 | -3.0 | · | -5.2 | -7.1 | -3.4 | · | -4.1 | -1.3 | -1.6 | · | -3.4 | -5.8 | -4.7 | · | -1.4 | |
| P/S | 0.6 | 1.0 | · | 1.6 | 2.2 | 1.8 | · | 2.7 | 1.3 | 1.7 | · | 2.2 | 4.3 | 4.2 | · | 1.6 | |
| P/B | -31.3 | 16.2 | · | 6.5 | 6.9 | 4.3 | · | 6.3 | 2.3 | 2.7 | · | 4.5 | 6.5 | 5.1 | · | 1.5 | |
| P / Tangible Book | · | · | · | 10.8 | 10.2 | 5.8 | · | 6.3 | 2.3 | 2.7 | · | 4.5 | 6.5 | 5.1 | · | 1.5 | |
| P / Cash Flow | · | -30.6 | · | · | · | -18.0 | · | · | · | -10.7 | · | · | · | -47.5 | · | · | |
| EV / Revenue | 1.0 | 1.3 | · | 1.8 | 2.3 | 1.8 | · | 3.0 | 1.4 | 1.5 | · | 2.1 | 4.1 | · | · | · | |
| Earnings Yield | -77.5% | -33.6% | · | -19.3% | -14.1% | -29.0% | · | -24.7% | -75.4% | -63.2% | · | -29.3% | -17.3% | -21.4% | · | -72.8% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|
| Umsatz | $37M | $36M | · | · | · |
| Bruttogewinnmarge % | · | 70.6% | · | · | · |
| Betriebsgewinnmarge % | · | -47.2% | · | · | · |
| Nettoergebnis | $-8M | $-21M | · | · | · |
| Verwässerte EPS | $-0.13 | $-0.38 | · | · | · |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | · | 1.3 | · | · | · |
| Liquiditätsgrad | · | 2.2 | · | · | · |
| Quick Ratio | · | 1.1 | · | · | · |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|
| Freier Cashflow | · | $-15M | · | · | · |
Institutionelle Eigentümer (13F) 55 Einreicher · $7.6M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
55
Gehaltener Wert
$7.6M
Neue Positionen
7
Geschlossene Positionen
6
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 7 (-3 vs. Vorquartal) | 6 (-1 vs. Vorquartal) | 12 (+3 vs. Vorquartal) | 13 (+1 vs. Vorquartal) | -320K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| AVENIR CORP | $1.940.768 | 5.189.218 | 25,56% | Aktien |
| VANGUARD GROUP INC | $1.408.544 | 2.204.294 | 18,55% | Aktien |
| NEUBERGER BERMAN GROUP LLC | $740.516 | 1.968.691 | 9,75% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $715.860 | 1.914.063 | 9,43% | Aktien |
| CM Management, LLC | $552.211 | 1.476.500 | 7,27% | Aktien |
| Skylands Capital, LLC | $453.064 | 1.211.400 | 5,97% | Aktien |
| BlackRock, Inc. | $234.577 | 627.211 | 3,09% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $225.239 | 602.059 | 2,97% | Aktien |
| Sargent Investment Group, LLC | $207.853 | 555.757 | 2,74% | Aktien |
| Pathstone Holdings, LLC | $186.966 | 499.910 | 2,46% | Aktien |
| CIBC Private Wealth Group LLC | $161.271 | 172.649 | 2,12% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $118.246 | 316.167 | 1,56% | Aktien |
| CIBC Bancorp USA Inc. | $64.571 | 172.649 | 0,85% | Aktien |
| STATE STREET CORP | $59.576 | 159.293 | 0,78% | Aktien |
| OSAIC HOLDINGS, INC. | $49.991 | 134.839 | 0,66% | Aktien |
| UBS Group AG | $49.001 | 131.019 | 0,65% | Aktien |
| NORTHERN TRUST CORP | $41.761 | 111.660 | 0,55% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $40.247 | 107.611 | 0,53% | Aktien |
| NWF Advisory Services Inc. | $38.947 | 104.139 | 0,51% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $37.407 | 100.020 | 0,49% | Aktien |
| MORGAN STANLEY | $34.160 | 91.338 | 0,45% | Aktien |
| Key Client Fiduciary Advisors, LLC | $29.343 | 78.457 | 0,39% | Aktien |
| XTX Topco Ltd | $20.314 | 54.316 | 0,27% | Aktien |
| JANE STREET GROUP, LLC | $19.525 | 52.205 | 0,26% | Aktien |
| LPL Financial LLC | $18.744 | 50.119 | 0,25% | Aktien |
| STIFEL FINANCIAL CORP | $17.952 | 48.000 | 0,24% | Aktien |
| BANK OF AMERICA CORP /DE/ | $14.468 | 38.686 | 0,19% | Aktien |
| COUNTRY CLUB BANK /GFN | $14.089 | 15.225 | 0,19% | Aktien |
| Kestra Advisory Services, LLC | $10.547 | 28.200 | 0,14% | Aktien |
| EP Wealth Advisors, LLC | $10.472 | 28.000 | 0,14% | Aktien |
| RITHOLTZ WEALTH MANAGEMENT | $10.264 | 27.443 | 0,14% | Aktien |
| SFMG, LLC | $7.480 | 20.000 | 0,10% | Aktien |
| Creative Planning | $7.090 | 18.956 | 0,09% | Aktien |
| Seelaus Asset Management LLC | $6.096 | 16.300 | 0,08% | Aktien |
| FIRST NATIONAL BANK OF OMAHA | $5.811 | 15.225 | 0,08% | Aktien |
| GOLDMAN SACHS GROUP INC | $5.736 | 15.338 | 0,08% | Aktien |
| Merit Financial Group, LLC | $5.721 | 15.297 | 0,08% | Aktien |
| CITADEL ADVISORS LLC | $5.386 | 14.400 | 0,07% | Kaufoption |
| Vanguard Global Advisers, LLC | $5.186 | 13.865 | 0,07% | Aktien |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $4.180 | 11.176 | 0,06% | Aktien |
| Tower Research Capital LLC (TRC) | $3.823 | 10.223 | 0,05% | Aktien |
| MARATHON CAPITAL MANAGEMENT | $3.740 | 10.000 | 0,05% | Aktien |
| COMERICA BANK | $2.796 | 4.376 | 0,04% | Aktien |
| FIFTH THIRD BANCORP | $1.155 | 3.090 | 0,02% | Aktien |
| Global Retirement Partners, LLC | $882 | 2.358 | 0,01% | Aktien |
| Rockefeller Capital Management L.P. | $618 | 1.652 | 0,01% | Aktien |
| JPMORGAN CHASE & CO | $142 | 372 | 0,00% | Aktien |
| BARCLAYS PLC | $107 | 287 | 0,00% | Aktien |
| WELLS FARGO & COMPANY/MN | $94 | 250 | 0,00% | Aktien |
| Virtu Financial LLC | $27 | 71.508 | 0,00% | Aktien |
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Guillermina Vega Montiel | 24. Juli 2006 | · | Erste Einreichung | · | SEC |
| Joseph Bowes | 13. Juli 2006 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 23 Insider · 9 Führungskräfte · 8 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Phillip P. Chan | Chief Executive Officer | 15. September 2026 P | 100.996 | 4 | 0 | $197.541 |
| Peter J Mariani | Chief Financial Officer | 15. Juni 2026 P | 638.113 | 1 | 0 | $44.000 |
| Kathleen P. Bloch | Chief Financial Officer | 2. April 2024 A | 532.941 | 0 | 0 | $0 |
| Ronald Berger | Interim CFO | 4. April 2013 A | · | 0 | 0 | $0 |
| David Lamadrid | Chief Financial Officer | 6. September 2011 M | 7.837.500 | 0 | 0 | $0 |
| Vincent Capponi | President and COO | 14. September 2026 P | 40.387 | 2 | 0 | $12.537 |
| Efthymios Deliargyris | Chief Medical Officer | 8. August 2025 A | 473.025 | 0 | 0 | $0 |
| Eric R. Mortensen | Chief Medical Officer | 14. August 2019 M | 148.932 | 0 | 0 | $0 |
| Robert Hawes Bartlett | Chief Medical Officer | 24. Februar 2017 A | 30.000 | 0 | 0 | $0 |
| Alan D. Sobel | Direktor | 15. September 2026 P | 9.887 | 3 | 0 | $15.254 |
| Jiny Kim | Direktor | 8. August 2025 A | 77.819 | 0 | 0 | $0 |
| Michael G. Bator | Direktor | 8. August 2025 A | 151.273 | 0 | 0 | $0 |
| Edward Raymond Jones | Direktor | 8. August 2025 A | 88.834 | 0 | 0 | $0 |
| Kraus Al | Direktor | 6. Februar 2023 M | 142.046 | 0 | 0 | $0 |
| James T. Gunton | Direktor | 8. April 2015 A | 55.000 | 0 | 0 | $0 |
| Joseph Rubin | Direktor | 28. März 2014 A | 167.213 | 0 | 0 | $0 |
| NJTC INVESTMENT FUND, LP | 10%-Eigentümer | 8. April 2015 A | 2.554.999 | 0 | 0 | $0 |
| James F Winchester | · | 25. Juni 2008 A | · | 0 | 0 | $0 |
| Kurt Katz | · | 25. Juni 2008 A | · | 0 | 0 | $0 |
| MILLER WILLIAM R | · | 25. Juni 2008 A | · | 0 | 0 | $0 |
| Martin F Whalen | · | 31. Dezember 2007 A | · | 0 | 0 | $0 |
| Margie Chassman | · | 28. Oktober 2006 J | 4.795.000 | 0 | 0 | $0 |
| Joseph G Bowes | · | 6. Juli 2006 C | 0 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 2 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
CTSO Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 6 Analysten
VERKAUF
Median-Ziel
$47.50
+1072,8%
0 0,0%
Starker Kauf
0 0,0%
Kauf
3 50,0%
Halten
1 16,7%
Verkauf
2 33,3%
Starker Verkauf
12-Monats-Kursziel
2 Analysten · 2026-10-01Mittelwert-Ziel $47.50 +1072,8%
← Unter allen Zielen
Aktueller Preis $4.05
Tief$15.00
Mittelwert$47.50
Hoch$80.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| CTSO | · | -4.9 | 4.1% | · | · | · |
| FEMY | $34M | -1.2 | 40.8% | -812.3% | -505.0% | · |
| SINT | $15M | -0.6 | -64.7% | -1018.1% | -299.7% | 45.3% |
| IRIX | $20M | -4.5 | 8.2% | -8.4% | -80.8% | 36.5% |
| AEMD | $3M | -0.2 | · | · | -134.5% | · |
| BMRA | · | -1.8 | -16.2% | · | · | · |
| NMTC | · | -9.9 | 163.5% | · | · | · |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026